China Medical System HoldingsCHSYF 87 EV-to-FCF is 44.71 as of Jul. 02, 2026, which is 306% above its 10-year median of 11.01. GuruFocus rates CHSYF with a GF Score™ of 87/100 and a GF Value™ of $1.28 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 561 Drug Manufacturers companies, China Medical System Holdings ranks worse than 72.37% on this metric.
The historical rank and industry rank for China Medical System Holdings's EV-to-FCF or its related term are showing as below:
CHSYF'
s EV-to-FCF Range Over the Past 10 Years
Min: 4.38 Med: 11.01 Max: 2544.46
Current: 43.1
During the past 13 years, the highest EV-to-FCF of China Medical System Holdings was 2544.46. The lowest was 4.38. And the median was 11.01.
CHSYF's EV-to-FCF is ranked worse than 72.37% of 561
companies
in the Drug Manufacturers industry
Industry Median: 20.16
vs CHSYF: 43.10
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Medical System Holdings (OTCPK:CHSYF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Medical System Holdings's PE Ratio (TTM) for today is calculated as:
China Medical System Holdings's share price for today is $1.56825.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical System Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.086.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China Medical System Holdings EV-to-FCF Related Terms
China Medical System Holdings EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Medical System Holdings EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China Medical System Holdings's EV-to-FCF falls into.
China Medical System Holdings's current Enterprise Value is $2,461 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical System Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Medical System Holdings (CHSYF) has a EV-to-FCF of 44.71 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Medical System Holdings and its competitors. This is 306% above median its historical median of 11.01. Over the past decade, China Medical System Holdings' EV-to-FCF has ranged from 4.38 to 2,544.46. According to the industry distribution chart, China Medical System Holdings ranks #406 out of 561 companies in the Drug Manufacturers industry, placing it in the top 72.4%.
Is China Medical System Holdings' EV-to-FCF too high?
China Medical System Holdings' current EV-to-FCF of 44.71 is 306% above median its 10-year median of 11.01. Over the past 10 years, this metric has ranged from a low of 4.38 to a high of 2,544.46. The Drug Manufacturers industry median EV-to-FCF is 20.16. China Medical System Holdings' value of 44.71 is 121.8% above this industry median. Based on the distribution chart, China Medical System Holdings ranks #406 out of 561 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, China Medical System Holdings has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Medical System Holdings' EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, China Medical System Holdings ranks #406 out of 561 companies for EV-to-FCF. This places China Medical System Holdings in the lower half of its industry. The industry median EV-to-FCF is 20.16. China Medical System Holdings' value of 44.71 is 121.8% above this benchmark. Historically, China Medical System Holdings' own EV-to-FCF has ranged from 4.38 to 2,544.46 over the past decade. While the company's 10-year median is 11.01 vs. the industry median of 20.16, China Medical System Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.16, based on 561 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Medical System Holdings's current EV-to-FCF of 44.71 is 121.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Medical System Holdings and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Medical System Holdings's current EV-to-FCF is 44.71, which is 306% above median its own 10-year median of 11.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Medical System Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Medical System Holdings (CHSYF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.28, compared to a current price of $1.57 — trading 22.5% above its estimated fair value. The current EV-to-FCF is 44.71, which is 306% above median its 10-year median of 11.01 and 121.8% above the Drug Manufacturers industry median of 20.16. China Medical System Holdings' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For China Medical System Holdings (CHSYF), the current EV-to-FCF is 44.71 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Medical System Holdings (CHSYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Medical System Holdings stock appears to be overvalued.
The current stock price of $1.57 is trading 22.5% above its estimated GF Value™ of $1.28.
GuruFocus considers China Medical System Holdings to be Modestly Overvalued.
Key valuation signals for CHSYF:
EV-to-FCF: 44.71 (306% above median its 10-year median of 11.01)
GF Value™: $1.28 vs. price of $1.57 (22.5% above fair value)
Industry Position: 121.8% above the Drug Manufacturers median (#406 of 561)
No single metric tells the full story. See the CHSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Medical System Holdings Business Description
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
87GF Score
Get the complete analysis for CHSYF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHSYF has been successfully added to your 
